Mast cells in atopic dermatitis

Current Opinion in Immunology

Volumn 21, Issue 6, 2009, Pages 666-678

  Kawakami, Toshiaki ^a   Ando, Tomoaki ^a   Kimura, Miho ^a   Wilson, Bridget S ^b   Kawakami, Yuko ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN E; PROSTAGLANDIN D2;

ATOPIC DERMATITIS; CLINICAL FEATURE; EXPERIMENTAL MOUSE; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; HUMAN; HUMORAL IMMUNITY; HYPERSENSITIVITY; IMMUNOPATHOLOGY; MAST CELL; MASTOCYTOSIS; NONHUMAN; PRURITUS; REVIEW; RISK FACTOR; SKIN PERMEABILITY; SKIN SENSITIZATION;

ALLERGENS; ANIMALS; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; HUMANS; IMMUNOGLOBULIN E; MAST CELLS; RECEPTORS, IGE;

EID: 70449598071     PISSN: 09527915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.coi.2009.09.006     Document Type: Review

References (150)

1. Kitamura Y., and Ito A. Mast cell-committed progenitors. Proc Natl Acad Sci USA 102 (2005) 11129-11130
2. Galli S.J. Mast cells and basophils. Curr Opin Hematol 7 (2000) 32-39
3. Galli S.J., Maurer M., and Lantz C.S. Mast cells as sentinels of innate immunity. Curr Opin Immunol 11 (1999) 53-59
4. Kalesnikoff J., and Galli S.J. New developments in mast cell biology. Nat Immunol 9 (2008) 1215-1223
5. Metz M., Piliponsky A.M., Chen C.C., Lammel V., Abrink M., Pejler G., Tsai M., and Galli S.J. Mast cells can enhance resistance to snake and honeybee venoms. Science 313 (2006) 526-530
6. McLachlan J.B., Hart J.P., Pizzo S.V., Shelburne C.P., Staats H.F., Gunn M.D., and Abraham S.N. Mast cell-derived tumor necrosis factor induces hypertrophy of draining lymph nodes during infection. Nat Immunol 4 (2003) 1199-1205
7. Grimbaldeston M.A., Nakae S., Kalesnikoff J., Tsai M., and Galli S.J. Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol 8 (2007) 1095-1104
8. Secor V.H., Secor W.E., Gutekunst C.A., and Brown M.A. Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med 191 (2000) 813-822
9. Lee D.M., Friend D.S., Gurish M.F., Benoist C., Mathis D., and Brenner M.B. Mast cells: a cellular link between autoantibodies and inflammatory arthritis. Science 297 (2002) 1689-1692
10. Lu L.F., Lind E.F., Gondek D.C., Bennett K.A., Gleeson M.W., Pino-Lagos K., Scott Z.A., Coyle A.J., Reed J.L., Van Snick J., et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442 (2006) 997-1002
11. Heissig B., Rafii S., Akiyama H., Ohki Y., Sato Y., Rafael T., Zhu Z., Hicklin D.J., Okumura K., Ogawa H., et al. Low-dose irradiation promotes tissue revascularization through VEGF release from mast cells and MMP-9-mediated progenitor cell mobilization. J Exp Med 202 (2005) 739-750
12. Coussens L.M., Raymond W.W., Bergers G., Laig-Webster M., Behrendtsen O., Werb Z., Caughey G.H., and Hanahan D. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13 (1999) 1382-1397
13. Soucek L., Lawlor E.R., Soto D., Shchors K., Swigart L.B., and Evan G.I. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 13 (2007) 1211-1218
14. Kinet J.P. The high-affinity IgE receptor (Fc epsilon RI): from physiology to pathology. Annu Rev Immunol 17 (1999) 931-972
15. Metzger H. The receptor with high affinity for IgE. Immunol Rev 125 (1992) 37-48
16. Finkelman F.D. Anaphylaxis: lessons from mouse models. J Allergy Clin Immunol 120 (2007) 506-515 quiz 516-507
17. Ong P.Y., Ohtake T., Brandt C., Strickland I., Boguniewicz M., Ganz T., Gallo R.L., and Leung D.Y. Endogenous antimicrobial peptides and skin infections in atopic dermatitis. N Engl J Med 347 (2002) 1151-1160
18. Strait R.T., Morris S.C., Yang M., Qu X.W., and Finkelman F.D. Pathways of anaphylaxis in the mouse. J Allergy Clin Immunol 109 (2002) 658-668
19. Tsujimura Y., Obata K., Mukai K., Shindou H., Yoshida M., Nishikado H., Kawano Y., Minegishi Y., Shimizu T., and Karasuyama H. Basophils play a pivotal role in immunoglobulin-G-mediated but not immunoglobulin-E-mediated systemic anaphylaxis. Immunity 28 (2008) 581-589
20. Galli S.J. Complexity and redundancy in the pathogenesis of asthma: reassessing the roles of mast cells and T cells. J Exp Med 186 (1997) 343-347
21. Kobayashi T., Miura T., Haba T., Sato M., Serizawa I., Nagai H., and Ishizaka K. An essential role of mast cells in the development of airway hyperresponsiveness in a murine asthma model. J Immunol 164 (2000) 3855-3861
22. Williams C.M., and Galli S.J. Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice. J Exp Med 192 (2000) 455-462
23. Yu M., Tsai M., Tam S.Y., Jones C., Zehnder J., and Galli S.J. Mast cells can promote the development of multiple features of chronic asthma in mice. J Clin Invest 116 (2006) 1633-1641
24. Bradding P. The role of the mast cell in asthma: a reassessment. Curr Opin Allergy Clin Immunol 3 (2003) 45-50
25. Robinson D.S. The role of the mast cell in asthma: induction of airway hyperresponsiveness by interaction with smooth muscle?. J Allergy Clin Immunol 114 (2004) 58-65
26. Tunon-de-Lara J.M., Berger P., and Begueret H. Mast cells in airway smooth muscle. N Engl J Med 347 (2002) 1040-1041 author reply 1040-1041
27. D'Amato G., Liccardi G., Noschese P., Salzillo A., D'Amato M., and Cazzola M. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases. Curr Drug Targets Inflamm Allergy 3 (2004) 227-229
28. Spector S. Omalizumab: efficacy in allergic disease. Panminerva Med 46 (2004) 141-148
29. Nakano T., Sonoda T., Hayashi C., Yamatodani A., Kanayama Y., Yamamura T., Asai H., Yonezawa T., Kitamura Y., and Galli S.J. Fate of bone marrow-derived cultured mast cells after intracutaneous, intraperitoneal, and intravenous transfer into genetically mast cell-deficient W/Wv mice. Evidence that cultured mast cells can give rise to both connective tissue type and mucosal mast cells. J Exp Med 162 (1985) 1025-1043
30. Galli S.J., Zsebo K.M., and Geissler E.N. The kit ligand, stem cell factor. Adv Immunol 55 (1994) 1-96
31. Okayama Y., and Kawakami T. Development, migration, and survival of mast cells. Immunol Res 34 (2006) 97-115
32. Metz M., Grimbaldeston M.A., Nakae S., Piliponsky A.M., Tsai M., and Galli S.J. Mast cells in the promotion and limitation of chronic inflammation. Immunol Rev 217 (2007) 304-328
33. Leung D.Y., and Bieber T. Atopic dermatitis. Lancet 361 (2003) 151-160
34. Geha R.S. Allergy and hypersensitivity. Nature versus nurture in allergy and hypersensitivity. Curr Opin Immunol 15 (2003) 603-608
35. Bieber T. Atopic dermatitis. N Engl J Med 358 (2008) 1483-1494
36. Leung D.Y.M. New insights into the complex gene-environment interactions evolving into atopic dermatitis. J Allergy Clin Immunol 118 (2006) 37-39
37. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol 4 (2004) 978-988
38. Esparza-Gordillo J., Weidinger S., Folster-Holst R., Bauerfeind A., Ruschendorf F., Patone G., Rohde K., Marenholz I., Schulz F., Kerscher T., et al. A common variant on chromosome 11q13 is associated with atopic dermatitis. Nat Genet (2009)
39. Graves P.E., Siroux V., Guerra S., Klimecki W.T., and Martinez F.D. Association of atopy and eczema with polymorphisms in T-cell immunoglobulin domain and mucin domain-IL-2-inducible T-cell kinase gene cluster in chromosome 5 q 33. J Allergy Clin Immunol 116 (2005) 650-656
40. Novak N., Kruse S., Potreck J., Maintz L., Jenneck C., Weidinger S., Fimmers R., and Bieber T. Single nucleotide polymorphisms of the IL18 gene are associated with atopic eczema. J Allergy Clin Immunol 115 (2005) 828-833
41. Soumelis V., Reche P.A., Kanzler H., Yuan W., Edward G., Homey B., Gilliet M., Ho S., Antonenko S., Lauerma A., et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP. Nat Immunol 3 (2002) 673-680
42. Liu Y.J. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med 203 (2006) 269-273
43. Yoo J., Omori M., Gyarmati D., Zhou B., Aye T., Brewer A., Comeau M.R., Campbell D.J., and Ziegler S.F. Spontaneous atopic dermatitis in mice expressing an inducible thymic stromal lymphopoietin transgene specifically in the skin. J Exp Med 202 (2005) 541-549
44. Li M., Messaddeq N., Teletin M., Pasquali J.L., Metzger D., and Chambon P. Retinoid X receptor ablation in adult mouse keratinocytes generates an atopic dermatitis triggered by thymic stromal lymphopoietin. Proc Natl Acad Sci USA 102 (2005) 14795-14800
45. Elias P.M., Hatano Y., and Williams M.L. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 121 (2008) 1337-1343
46. Elias P.M., and Steinhoff M. Outside-to-inside (and now back to 'outside') pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 128 (2008) 1067-1070
47. Kato A., Fukai K., Oiso N., Hosomi N., Murakami T., and Ishii M. Association of SPINK5 gene polymorphisms with atopic dermatitis in the Japanese population. Br J Dermatol 148 (2003) 665-669
48. Nishio Y., Noguchi E., Shibasaki M., Kamioka M., Ichikawa E., Ichikawa K., Umebayashi Y., Otsuka F., and Arinami T. Association between polymorphisms in the SPINK5 gene and atopic dermatitis in the Japanese. Genes Immun 4 (2003) 515-517
49. Walley A.J., Chavanas S., Moffatt M.F., Esnouf R.M., Ubhi B., Lawrence R., Wong K., Abecasis G.R., Jones E.Y., Harper J.I., et al. Gene polymorphism in Netherton and common atopic disease. Nat Genet 29 (2001) 175-178
50. Palmer C.N., Irvine A.D., Terron-Kwiatkowski A., Zhao Y., Liao H., Lee S.P., Goudie D.R., Sandilands A., Campbell L.E., Smith F.J., et al. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 38 (2006) 441-446. This study demonstrated that loss-of-function mutations in the filaggrin gene are very strong predisposing factors for atopic dermatitis, as these variants are carried by approximately 9% of people of European origin.
51. Morar N., Willis-Owen S.A., Moffatt M.F., and Cookson W.O. The genetics of atopic dermatitis. J Allergy Clin Immunol 118 (2006) 24-34 quiz 35-26
52. Sandilands A., Terron-Kwiatkowski A., Hull P.R., O'Regan G.M., Clayton T.H., Watson R.M., Carrick T., Evans A.T., Liao H., Zhao Y., et al. Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet 39 (2007) 650-654
53. Nomura T., Sandilands A., Akiyama M., Liao H., Evans A.T., Sakai K., Ota M., Sugiura H., Yamamoto K., Sato H., et al. Unique mutations in the filaggrin gene in Japanese patients with ichthyosis vulgaris and atopic dermatitis. J Allergy Clin Immunol 119 (2007) 434-440
54. Fallon P.G., Sasaki T., Sandilands A., Campbell L.E., Saunders S.P., Mangan N.E., Callanan J.J., Kawasaki H., Shiohama A., Kubo A., et al. A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet 41 (2009) 602-608. This study reports a 1-bp deletion mutation, 5303delA, within the filaggrin gene in the spontaneous mouse mutant flaky tail (ft).
55. Tosi M.F. Innate immune responses to infection. J Allergy Clin Immunol 116 (2005) 241-249 quiz 250
56. Strange P., Skov L., Lisby S., Nielsen P.L., and Baadsgaard O. Staphylococcal enterotoxin B applied on intact normal and intact atopic skin induces dermatitis. Arch Dermatol 132 (1996) 27-33
57. Jappe U. Superantigens and their association with dermatological inflammatory diseases: facts and hypotheses. Acta Derm Venereol 80 (2000) 321-328
58. Beck L.A., Boguniewicz M., Hata T., Schneider L.C., Hanifin J., Gallo R., Paller A.S., Lieff S., Reese J., Zaccaro D., et al. Phenotype of atopic dermatitis subjects with a history of eczema herpeticum. J Allergy Clin Immunol (2009)
59. Matsuda H., Watanabe N., Geba G.P., Sperl J., Tsudzuki M., Hiroi J., Matsumoto M., Ushio H., Saito S., Askenase P.W., et al. Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice. Int Immunol 9 (1997) 461-466
60. Gutermuth J., Ollert M., Ring J., Behrendt H., and Jakob T. Mouse models of atopic eczema critically evaluated. Int Arch Allergy Immunol 135 (2004) 262-276
61. Jin H., He R., Oyoshi M., and Geha R.S. Animal models of atopic dermatitis. J Invest Dermatol 129 (2009) 31-40. This is a superb review of animal models of AD.
62. Vestergaard C., Yoneyama H., Murai M., Nakamura K., Tamaki K., Terashima Y., Imai T., Yoshie O., Irimura T., Mizutani H., et al. Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions. J Clin Invest 104 (1999) 1097-1105
63. Matsumoto M., Ra C., Kawamoto K., Sato H., Itakura A., Sawada J., Ushio H., Suto H., Mitsuishi K., Hikasa Y., et al. IgE hyperproduction through enhanced tyrosine phosphorylation of Janus kinase 3 in NC/Nga mice, a model for human atopic dermatitis. J Immunol 162 (1999) 1056-1063
64. Yagi R., Nagai H., Iigo Y., Akimoto T., Arai T., and Kubo M. Development of atopic dermatitis-like skin lesions in STAT6-deficient NC/Nga mice. J Immunol 168 (2002) 2020-2027
65. Iijima O.T., Takeda H., Komatsu Y., Matsumiya T., and Takahashi H. Atopic dermatitis in NC/Jic mice associated with Myobia musculi infestation. Comp Med 50 (2000) 225-228
66. Morita E., Kaneko S., Hiragun T., Shindo H., Tanaka T., Furukawa T., Nobukiyo A., and Yamamoto S. Fur mites induce dermatitis associated with IgE hyperproduction in an inbred strain of mice, NC/Kuj. J Dermatol Sci 19 (1999) 37-43
67. Gao X.K., Nakamura N., Fuseda K., Tanaka H., Inagaki N., and Nagai H. Establishment of allergic dermatitis in NC/Nga mice as a model for severe atopic dermatitis. Biol Pharm Bull 27 (2004) 1376-1381
68. Heishi M., Imai Y., Katayama H., Hashida R., Ito M., Shinagawa A., and Sugita Y. Gene expression analysis of atopic dermatitis-like skin lesions induced in NC/Nga mice by mite antigen stimulation under specific pathogen-free conditions. Int Arch Allergy Immunol 132 (2003) 355-363
69. Kang J.S., Lee K., Han S.B., Ahn J.M., Lee H., Han M.H., Yoon Y.D., Yoon W.K., Park S.K., and Kim H.M. Induction of atopic eczema/dermatitis syndrome-like skin lesions by repeated topical application of a crude extract of Dermatophagoides pteronyssinus in NC/Nga mice. Int Immunopharmacol 6 (2006) 1616-1622
70. Matsuoka H., Maki N., Yoshida S., Arai M., Wang J., Oikawa Y., Ikeda T., Hirota N., Nakagawa H., and Ishii A. A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae. Allergy 58 (2003) 139-145
71. Unno T., Suto H., Yoshiike T., Ogawa H., and Ra C. Induction of atopic dermatitis-like skin lesion in NC/Nga mice-the influence of the skin barrier destroying solution to the induction of dermatitis. Arerugi 50 (2001) 1152-1162
72. Kawakami Y., Yumoto K., and Kawakami T. An improved mouse model of atopic dermatitis and suppression of skin lesions by an inhibitor of tec family kinases. Allergol Int 56 (2007) 403-409
73. Kawakami Y., Tomimori Y., Yumoto K., Hasegawa S., Ando T., Tagaya Y., Crotty S., and Kawakami T. Inhibition of NK cell activity by IL-17 allows vaccinia virus to induce severe skin lesions in a mouse model of eczema vaccinatum. J Exp Med 206 (2009) 1219-1225
74. Wang L.F., Lin J.Y., Hsieh K.H., and Lin R.H. Epicutaneous exposure of protein antigen induces a predominant Th2-like response with high IgE production in mice. J Immunol 156 (1996) 4077-4082
75. Strid J., Hourihane J., Kimber I., Callard R., and Strobel S. Disruption of the stratum corneum allows potent epicutaneous immunization with protein antigens resulting in a dominant systemic Th2 response. Eur J Immunol 34 (2004) 2100-2109
76. Spergel J.M., Mizoguchi E., Brewer J.P., Martin T.R., Bhan A.K., and Geha R.S. Epicutaneous sensitization with protein antigen induces localized allergic dermatitis and hyperresponsiveness to methacholine after single exposure to aerosolized antigen in mice. J Clin Invest 101 (1998) 1614-1622
77. Spergel J.M., Mizoguchi E., Oettgen H., Bhan A.K., and Geha R.S. Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis. J Clin Invest 103 (1999) 1103-1111
78. He R., Oyoshi M.K., Jin H., and Geha R.S. Epicutaneous antigen exposure induces a Th17 response that drives airway inflammation after inhalation challenge. Proc Natl Acad Sci USA 104 (2007) 15817-15822. This study showed that EC immunization with OVA drive IL-17 expression in the skin by IL-23 and TGF-β-dependent manner.
79. Alenius H., Laouini D., Woodward A., Mizoguchi E., Bhan A.K., Castigli E., Oettgen H.C., and Geha R.S. Mast cells regulate IFN-gamma expression in the skin and circulating IgE levels in allergen-induced skin inflammation. J Allergy Clin Immunol 109 (2002) 106-113
80. Oiwa M., Satoh T., Watanabe M., Niwa H., Hirai H., Nakamura M., and Yokozeki H. CRTH2-dependent, STAT6-independent induction of cedar pollen dermatitis. Clin Exp Allergy 38 (2008) 1357-1366
81. Abboud G., Staumont-Salle D., Kanda A., Roumier T., Deruytter N., Lavogiez C., Fleury S., Remy P., Papin J.P., Capron M., et al. FcεRI and FcγRIII/CD16 differentially regulate atopic dermatitis in mice. J Immunol 182 (2009) 6517-6526. Using an EC OVA sensitization model, this study demonstrated the contribution of FcεRI and FcγRIII/CD16 to the AD pathology.
82. Gonzalez de Olano D., de la Hoz Caballer B., Nunez Lopez R., Sanchez Munoz L., Cuevas Agustin M., Dieguez M.C., Alvarez Twose I., Castells M.C., and Escribano Mora L. Prevalence of allergy and anaphylactic symptoms in 210 adult and pediatric patients with mastocytosis in Spain: a study of the Spanish network on mastocytosis (REMA). Clin Exp Allergy 37 (2007) 1547-1555
83. Kunisada T., Lu S.Z., Yoshida H., Nishikawa S., Mizoguchi M., Hayashi S., Tyrrell L., Williams D.A., Wang X., and Longley B.J. Murine cutaneous mastocytosis and epidermal melanocytosis induced by keratinocyte expression of transgenic stem cell factor. J Exp Med 187 (1998) 1565-1573
84. Tanaka T., Tsutsui H., Yoshimoto T., Kotani M., Matsumoto M., Fujita A., Wang W., Higa S., Koshimoto T., Nakanishi K., et al. Interleukin-18 is elevated in the sera from patients with atopic dermatitis and from atopic dermatitis model mice, NC/Nga. Int Arch Allergy Immunol 125 (2001) 236-240
85. Nakano H., Tsutsui H., Terada M., Yasuda K., Matsui K., Yumikura-Futatsugi S., Yamanaka K., Mizutani H., Yamamura T., and Nakanishi K. Persistent secretion of IL-18 in the skin contributes to IgE response in mice. Int Immunol 15 (2003) 611-621
86. Terada M., Tsutsui H., Imai Y., Yasuda K., Mizutani H., Yamanishi K., Kubo M., Matsui K., Sano H., and Nakanishi K. Contribution of IL-18 to atopic-dermatitis-like skin inflammation induced by Staphylococcus aureus product in mice. Proc Natl Acad Sci USA 103 (2006) 8816-8821. This study showed the importance of IL-18 for the development of infection-associated AD by induction of IL-3 from super Th1 cells.
87. Novak N., Valenta R., Bohle B., Laffer S., Haberstok J., Kraft S., and Bieber T. FcepsilonRI engagement of Langerhans cell-like dendritic cells and inflammatory dendritic epidermal cell-like dendritic cells induces chemotactic signals and different T-cell phenotypes in vitro. J Allergy Clin Immunol 113 (2004) 949-957
88. Chen L., Overbergh L., Mathieu C., and Chan L.S. The development of atopic dermatitis is independent of Immunoglobulin E up-regulation in the K14-IL-4 SKH1 transgenic mouse model. Clin Exp Allergy 38 (2008) 1367-1380
89. Dillon S.R., Sprecher C., Hammond A., Bilsborough J., Rosenfeld-Franklin M., Presnell S.R., Haugen H.S., Maurer M., Harder B., Johnston J., et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol 5 (2004) 752-760
90. Boehme S.A., Franz-Bacon K., Chen E.P., Ly T.W., Kawakami Y., and Bacon K.B. Murine bone marrow-derived mast cells express chemoattractant receptor-homologous molecule expressed on T-helper class 2 cells (CRTh2). Int Immunol 21 (2009) 621-632
91. Spik I., Brenuchon C., Angeli V., Staumont D., Fleury S., Capron M., Trottein F., and Dombrowicz D. Activation of the prostaglandin D2 receptor DP2/CRTH2 increases allergic inflammation in mouse. J Immunol 174 (2005) 3703-3708
92. Boehme S.A., Chen E.P., Franz-Bacon K., Sasik R., Sprague L.J., Ly T.W., Hardiman G., and Bacon K.B. Antagonism of CRTH2 ameliorates chronic epicutaneous sensitization-induced inflammation by multiple mechanisms. Int Immunol 21 (2009) 1-17
93. Boehme S.A., Franz-Bacon K., Chen E.P., Sasik R., Sprague L.J., Ly T.W., Hardiman G., and Bacon K.B. A small molecule CRTH2 antagonist inhibits FITC-induced allergic cutaneous inflammation. Int Immunol 21 (2009) 81-93
94. Satoh T., Moroi R., Aritake K., Urade Y., Kanai Y., Sumi K., Yokozeki H., Hirai H., Nagata K., Hara T., et al. Prostaglandin D2 plays an essential role in chronic allergic inflammation of the skin via CRTH2 receptor. J Immunol 177 (2006) 2621-2629
95. Yosipovitch G., Greaves M.W., and Schmelz M. Itch. Lancet 361 (2003) 690-694
96. Yamamoto M., Haruna T., Ueda C., Asano Y., Takahashi H., Iduhara M., Takaki S., Yasui K., Matsuo Y., and Arimura A. Contribution of itch-associated scratch behavior to the development of skin lesions in Dermatophagoides farinae-induced dermatitis model in NC/Nga mice. Arch Dermatol Res (2008)
97. Matsushima H., Hayashi S., and Shimada S. Skin scratching switches immune responses from Th2 to Th1 type in epicutaneously immunized mice. J Dermatol Sci 32 (2003) 223-230
98. Krause L., and Shuster S. Mechanism of action of antipruritic drugs. Br Med J (Clin Res Ed) 287 (1983) 1199-1200
99. Fujii M., Nabe T., Tomozawa J., and Kohno S. Involvement of skin barrier dysfunction in itch-related scratching in special diet-fed hairless mice. Eur J Pharmacol 530 (2006) 152-156
100. Naukkarinen A., Harvima I.T., Aalto M.L., and Horsmanheimo M. Mast cell tryptase and chymase are potential regulators of neurogenic inflammation in psoriatic skin. Int J Dermatol 33 (1994) 361-366
101. Stead R.H., Tomioka M., Quinonez G., Simon G.T., Felten S.Y., and Bienenstock J. Intestinal mucosal mast cells in normal and nematode-infected rat intestines are in intimate contact with peptidergic nerves. Proc Natl Acad Sci USA 84 (1987) 2975-2979
102. Metcalfe D.D., Baram D., and Mekori Y.A. Mast cells. Physiol Rev 77 (1997) 1033-1079
103. Naukkarinen A., Harvima I., Paukkonen K., Aalto M.L., and Horsmanheimo M. Immunohistochemical analysis of sensory nerves and neuropeptides, and their contacts with mast cells in developing and mature psoriatic lesions. Arch Dermatol Res 285 (1993) 341-346
104. Steinhoff M., Vergnolle N., Young S.H., Tognetto M., Amadesi S., Ennes H.S., Trevisani M., Hollenberg M.D., Wallace J.L., Caughey G.H., et al. Agonists of proteinase-activated receptor 2 induce inflammation by a neurogenic mechanism. Nat Med 6 (2000) 151-158
105. Molino M., Barnathan E.S., Numerof R., Clark J., Dreyer M., Cumashi A., Hoxie J.A., Schechter N., Woolkalis M., and Brass L.F. Interactions of mast cell tryptase with thrombin receptors and PAR-2. J Biol Chem 272 (1997) 4043-4049
106. Steinhoff M., Neisius U., Ikoma A., Fartasch M., Heyer G., Skov P.S., Luger T.A., and Schmelz M. Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin. J Neurosci 23 (2003) 6176-6180
107. Ui H., Andoh T., Lee J.B., Nojima H., and Kuraishi Y. Potent pruritogenic action of tryptase mediated by PAR-2 receptor and its involvement in anti-pruritic effect of nafamostat mesilate in mice. Eur J Pharmacol 530 (2006) 172-178
108. Miyamoto T., Nojima H., Shinkado T., Nakahashi T., and Kuraishi Y. Itch-associated response induced by experimental dry skin in mice. Jpn J Pharmacol 88 (2002) 285-292
109. Yamashita H., Michibata Y., Mizukami H., Ogihara Y., Morita A., and Nose M. Dermal mast cells play a central role in the incidence of scratching behavior in mice induced by multiple application of the hapten, 2,4,6-trinitrochlorobenzene. Exp Dermatol 14 (2005) 438-444
110. Yu C.K., and Chen C.L. Activation of mast cells is essential for development of house dust mite Dermatophagoides farinae-induced allergic airway inflammation in mice. J Immunol 171 (2003) 3808-3815
111. Mayr S.I., Zuberi R.I., Zhang M., de Sousa-Hitzler J., Ngo K., Kuwabara Y., Yu L., Fung-Leung W.P., and Liu F.T. IgE-dependent mast cell activation potentiates airway responses in murine asthma models. J Immunol 169 (2002) 2061-2068
112. Di Cesare A., Di Meglio P., and Nestle F.O. A role for Th17 cells in the immunopathogenesis of atopic dermatitis?. J Invest Dermatol 128 (2008) 2569-2571
113. Kohara Y., Tanabe K., Matsuoka K., Kanda N., Matsuda H., Karasuyama H., and Yonekawa H. A major determinant quantitative-trait locus responsible for atopic dermatitis-like skin lesions in NC/Nga mice is located on Chromosome 9. Immunogenetics 53 (2001) 15-21
114. Matsubara T., Aoki N., Hino S., Okajima T., Nadano D., and Matsuda T. Serum and monoclonal immunoglobulin E antibodies from NC/Nga mice with severe atopic-like dermatitis recognize an auto-antigen, histone H3. Clin Exp Allergy 39 (2009) 579-590
115. Terakawa M., Fujieda Y., Tomimori Y., Muto T., Tanaka T., Maruoka H., Nagahira K., Ogata A., Nakatsuka T., and Fukuda Y. Oral chymase inhibitor SUN13834 ameliorates skin inflammation as well as pruritus in mouse model for atopic dermatitis. Eur J Pharmacol 601 (2008) 186-191
116. Watanabe N., Tomimori Y., Terakawa M., Ishiwata K., Wada A., Muto T., Tanaka T., Maruoka H., Nagahira K., Nakatsuka T., et al. Oral administration of chymase inhibitor improves dermatitis in NC/Nga mice. J Invest Dermatol 127 (2007) 971-973
117. Tsujii K., Andoh T., Ui H., Lee J.B., and Kuraishi Y. Involvement of tryptase and proteinase-activated receptor-2 in spontaneous itch-associated response in mice with atopy-like dermatitis. J Pharmacol Sci 109 (2009) 388-395
118. Inoue T., Sugimoto M., Sakurai T., Saito R., Futaki N., Hashimoto Y., Honma Y., Arai I., and Nakaike S. Modulation of scratching behavior by silencing an endogenous cyclooxygenase-1 gene in the skin through the administration of siRNA. J Gene Med 9 (2007) 994-1001
119. Sugimoto M., Arai I., Futaki N., Hashimoto Y., Sakurai T., Honma Y., and Nakaike S. Time course changes of scratching counts, dermatitis symptoms, and levels of cutaneous prostaglandins in NC/Nga mice. Exp Dermatol 15 (2006) 875-882
120. Lane P.W. Two new mutations in linkage group XVI of the house mouse. Flaky tail and varitint-waddler-J. J Hered 63 (1972) 135-140
121. Presland R.B., Boggess D., Lewis S.P., Hull C., Fleckman P., and Sundberg J.P. Loss of normal profilaggrin and filaggrin in flaky tail (ft/ft) mice: an animal model for the filaggrin-deficient skin disease ichthyosis vulgaris. J Invest Dermatol 115 (2000) 1072-1081
122. Jong M.C., Gijbels M.J., Dahlmans V.E., Gorp P.J., Koopman S.J., Ponec M., Hofker M.H., and Havekes L.M. Hyperlipidemia and cutaneous abnormalities in transgenic mice overexpressing human apolipoprotein C1. J Clin Invest 101 (1998) 145-152
123. Nagelkerken L., Verzaal P., Lagerweij T., Persoon-Deen C., Berbee J.F., Prens E.P., Havekes L.M., and Oranje A.P. Development of atopic dermatitis in mice transgenic for human apolipoprotein C1. J Invest Dermatol 128 (2008) 1165-1172
124. Descargues P., Deraison C., Bonnart C., Kreft M., Kishibe M., Ishida-Yamamoto A., Elias P., Barrandon Y., Zambruno G., Sonnenberg A., et al. Spink5-deficient mice mimic Netherton syndrome through degradation of desmoglein 1 by epidermal protease hyperactivity. Nat Genet 37 (2005) 56-65
125. Demehri S., Morimoto M., Holtzman M.J., and Kopan R. Skin-derived TSLP triggers progression from epidermal-barrier defects to asthma. PLoS Biol 7 (2009) e1000067
126. Grubauer G., Feingold K.R., Harris R.M., and Elias P.M. Lipid content and lipid type as determinants of the epidermal permeability barrier. J Lipid Res 30 (1989) 89-96
127. Chan L.S., Robinson N., and Xu L. Expression of interleukin-4 in the epidermis of transgenic mice results in a pruritic inflammatory skin disease: an experimental animal model to study atopic dermatitis. J Invest Dermatol 117 (2001) 977-983
128. Konishi H., Tsutsui H., Murakami T., Yumikura-Futatsugi S., Yamanaka K., Tanaka M., Iwakura Y., Suzuki N., Takeda K., Akira S., et al. IL-18 contributes to the spontaneous development of atopic dermatitis-like inflammatory skin lesion independently of IgE/stat6 under specific pathogen-free conditions. Proc Natl Acad Sci USA 99 (2002) 11340-11345
129. Murakami T., Yamanaka K., Tokime K., Kurokawa I., Tsutsui H., Nakanishi K., and Mizutani H. Topical suplatast tosilate (IPD) ameliorates Th2 cytokine-mediated dermatitis in caspase-1 transgenic mice by downregulating interleukin-4 and interleukin-5. Br J Dermatol 155 (2006) 27-32
130. Yamanaka K., Tanaka M., Tsutsui H., Kupper T.S., Asahi K., Okamura H., Nakanishi K., Suzuki M., Kayagaki N., Black R.A., et al. Skin-specific caspase-1-transgenic mice show cutaneous apoptosis and pre-endotoxin shock condition with a high serum level of IL-18. J Immunol 165 (2000) 997-1003
131. Zheng T., Oh M.H., Oh S.Y., Schroeder J.T., Glick A.B., and Zhu Z. Transgenic expression of interleukin-13 in the skin induces a pruritic dermatitis and skin remodeling. J Invest Dermatol 129 (2009) 742-751
132. Sato H., Taketomi Y., Isogai Y., Masuda S., Kobayashi T., Yamamoto K., and Murakami M. Group III secreted phospholipase A2 transgenic mice spontaneously develop inflammation. Biochem J 421 (2009) 17-27
133. Li M., Hener P., Zhang Z., Kato S., Metzger D., and Chambon P. Topical vitamin D3 and low-calcemic analogs induce thymic stromal lymphopoietin in mouse keratinocytes and trigger an atopic dermatitis. Proc Natl Acad Sci USA 103 (2006) 11736-11741
134. Tsukuba T., Okamoto K., Okamoto Y., Yanagawa M., Kohmura K., Yasuda Y., Uchi H., Nakahara T., Furue M., Nakayama K., et al. Association of cathepsin E deficiency with development of atopic dermatitis. J Biochem (Tokyo) 134 (2003) 893-902
135. Barton D., HogenEsch H., and Weih F. Mice lacking the transcription factor RelB develop T cell-dependent skin lesions similar to human atopic dermatitis. Eur J Immunol 30 (2000) 2323-2332
136. Knisz J., Banks A., McKeag L., Metcalfe D.D., Rothman P.B., and Brown J.M. Loss of SOCS7 in mice results in severe cutaneous disease and increased mast cell activation. Clin Immunol (2009)
137. Sadri N., and Schneider R.J. Auf1/Hnrnpd-deficient mice develop pruritic inflammatory skin disease. J Invest Dermatol 129 (2009) 657-670
138. Asakawa M., Yoshioka T., Matsutani T., Hikita I., Suzuki M., Oshima I., Tsukahara K., Arimura A., Horikawa T., Hirasawa T., et al. Association of a mutation in TRPV3 with defective hair growth in rodents. J Invest Dermatol 126 (2006) 2664-2672
139. Haraguchi M., Hino M., Tanaka H., and Maru M. Naturally occurring dermatitis associated with Staphylococcus aureus in DS-Nh mice. Exp Anim 46 (1997) 225-229
140. Yoshioka T., Imura K., Asakawa M., Suzuki M., Oshima I., Hirasawa T., Sakata T., Horikawa T., and Arimura A. Impact of the Gly573Ser substitution in TRPV3 on the development of allergic and pruritic dermatitis in mice. J Invest Dermatol 129 (2009) 714-722
141. Fujii M., Tomozawa J., Mizutani N., Nabe T., Danno K., and Kohno S. Atopic dermatitis-like pruritic skin inflammation caused by feeding a special diet to HR-1 hairless mice. Exp Dermatol 14 (2005) 460-468
142. Makiura M., Akamatsu H., Akita H., Yagami A., Shimizu Y., Eiro H., Kuramoto M., Suzuki K., and Matsunaga K. Atopic dermatitis-like symptoms in HR-1 hairless mice fed a diet low in magnesium and zinc. J Int Med Res 32 (2004) 392-399
143. Watanabe O., Natori K., Tamari M., Shiomoto Y., Kubo S., and Nakamura Y. Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model for atopic dermatitis. J Hum Genet 44 (1999) 173-176
144. Kashiwakura J.I., Kawakami Y., Yuki K., Zajonc D.M., Hasegawa S., Tomimori Y., Caplan B., Saito H., Furue M., Oettgen H.C., et al. Polyclonal IgE induces mast cell survival and cytokine production. Allergol Int (2009) 58
145. Laouini D., Kawamoto S., Yalcindag A., Bryce P., Mizoguchi E., Oettgen H., and Geha R.S. Epicutaneous sensitization with superantigen induces allergic skin inflammation. J Allergy Clin Immunol 112 (2003) 981-987
146. Li X.M., Kleiner G., Huang C.K., Lee S.Y., Schofield B., Soter N.A., and Sampson H.A. Murine model of atopic dermatitis associated with food hypersensitivity. J Allergy Clin Immunol 107 (2001) 693-702
147. Herz U., Schnoy N., Borelli S., Weigl L., Kasbohrer U., Daser A., Wahn U., Kottgen E., and Renz H. A human-SCID mouse model for allergic immune response bacterial superantigen enhances skin inflammation and suppresses IgE production. J Invest Dermatol 110 (1998) 224-231
148. Kitagaki H., Fujisawa S., Watanabe K., Hayakawa K., and Shiohara T. Immediate-type hypersensitivity response followed by a late reaction is induced by repeated epicutaneous application of contact sensitizing agents in mice. J Invest Dermatol 105 (1995) 749-755
149. Nagai H., Matsuo A., Hiyama H., Inagaki N., and Kawada K. Immunoglobulin E production in mice by means of contact sensitization with a simple chemical, hapten. J Allergy Clin Immunol 100 (1997) S39-44
150. Webb E.F., Tzimas M.N., Newsholme S.J., and Griswold D.E. Intralesional cytokines in chronic oxazolone-induced contact sensitivity suggest roles for tumor necrosis factor alpha and interleukin-4. J Invest Dermatol 111 (1998) 86-92